{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:17:22Z","timestamp":1775801842921,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ncl.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T22:48:10Z","timestamp":1617230890000},"page":"615-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Movement Disorder Emergencies"],"prefix":"10.1016","volume":"39","author":[{"given":"Diana","family":"Apetauerova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritika A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2021.01.005_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov Disord"},{"issue":"960","key":"10.1016\/j.ncl.2021.01.005_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/pgmj.2004.032029","article-title":"Psychosis in Parkinson\u2019s disease","volume":"81","author":"Thanvi","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ncl.2021.01.005_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology, and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2021.01.005_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000129843.15756.A3","article-title":"Psychiatric comorbidities in patients with Parkinson disease and psychosis","volume":"63","author":"Marsh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.01.005_bib5","first-page":"759","article-title":"Risk factors for dementia, depression, and psychosis in long-standing Parkinson\u2019s disease","volume":"10","author":"Giladi","year":"2000","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.ncl.2021.01.005_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","article-title":"Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study","volume":"56","author":"Aarsland","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2021.01.005_bib7","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Consortium on DLB: Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.01.005_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/gps.389","article-title":"A\u00a0comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson\u2019s disease with and without dementia","volume":"16","author":"Aarsland","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.005_bib9","first-page":"319","article-title":"28th International Symposium on the autnomic system: Psychosis in Multiple System Atrophy","volume":"27","author":"Palma","year":"2017","journal-title":"Clin Auton Ress"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1155\/2013\/645429","article-title":"Parkinson\u2019s disease psychosis update","volume":"27","author":"Friedman","year":"2013","journal-title":"Behav Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0972-6748.77625","article-title":"Hallucinations: Clinical aspects and managements\u2019","volume":"10","author":"Chaudhury","year":"2000","journal-title":"Ind Psychiatry J"},{"key":"10.1016\/j.ncl.2021.01.005_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.parkreldis.2013.04.021","article-title":"Delusional misidentification syndrome and other unusual delusions in advanced Parkinson\u2019s disease","volume":"19","author":"Moro","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.ncl.2021.01.005_bib13","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archneur.64.12.1762","article-title":"Capgras syndrome and its relationship to neurodegenerative disease","volume":"64","author":"Josephs","year":"2007","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00702-015-1481-6","article-title":"Laboratory assessments in the course of Parkinson\u2019s disease: a clinician\u2019s perspective\u201d","volume":"123","author":"Muller","year":"2016","journal-title":"J\u00a0Neural Transm"},{"issue":"12","key":"10.1016\/j.ncl.2021.01.005_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40266-016-0416-8","article-title":"Psychosis in Parkinson disease: a review of etiology, phenomenology, and management","volume":"33","author":"Samudra","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ncl.2021.01.005_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","article-title":"Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson\u2019s disease, and Alzheimer\u2019s disease","volume":"640","author":"Perry","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2021.01.005_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2021.01.005_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the Cognitive Drug Research computerized assessment system","volume":"13","author":"Wesnes","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ncl.2021.01.005_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0278-5846(03)00040-X","article-title":"Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series","volume":"27","author":"Takahashi","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2021.01.005_bib20","first-page":"2780","article-title":"Parkinsonism\u2013hyperpyrexia syndrome and deep brain stimulation","volume":"262","author":"Artusi","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2021.01.005_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1353-8020(02)00122-0","article-title":"A collaborative study on the malignant syndrome in Parkinson's disease and related disorders","volume":"9","author":"Takubo","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib22","first-page":"15","article-title":"Emergencies and critical issues in Parkinson\u2019s disease","volume":"20","author":"Simonet","year":"2020","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.005_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/121.2.243","article-title":"Status dystonicus: the syndrome and its management","volume":"121","author":"Manji","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2021.01.005_bib24","doi-asserted-by":"crossref","unstructured":"Chang FCF, Frucht SJ. \"ICU Intensive Care Unit Movement Disorder Emergencies.\" Non-Parkinsonian Movement Disorders 2017;150\u201360.","DOI":"10.1002\/9781118474075.ch17"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40734-017-0057-z","article-title":"Frucht. \"Dystonic storm: a practical clinical and video review","volume":"4","author":"Termsarasab","year":"2017","journal-title":"J\u00a0Clin Movement Disord"},{"issue":"9","key":"10.1016\/j.ncl.2021.01.005_bib26","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/mds.20510","article-title":"Stimulation of the globus pallidus internus for childhood-onset dystonia","volume":"20","author":"Zorzi","year":"2005","journal-title":"Movement Disord"},{"key":"10.1016\/j.ncl.2021.01.005_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2019-002277","article-title":"Emergency presentations of movement disorders","author":"Gandhi","year":"2020","journal-title":"Pract Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2021.01.005_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.ncl.2021.01.005_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"NEJM"},{"issue":"9","key":"10.1016\/j.ncl.2021.01.005_bib30","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ncl.2021.01.005_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12883-016-0616-1","article-title":"Conundrums in neurology: diagnosing serotonin syndrome \u00e2\u20ac\u201c a meta-analysis of cases","volume":"16","author":"Werneke","year":"2016","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15563650701285289","article-title":"Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Nelson","year":"2007","journal-title":"Clin Toxicol"},{"issue":"11","key":"10.1016\/j.ncl.2021.01.005_bib33","first-page":"1439","article-title":"Serotonin syndrome: a brief review","volume":"168","author":"Birmes","year":"2003","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ncl.2021.01.005_bib34","doi-asserted-by":"crossref","unstructured":"Little K, Lin CM, Reynolds PM. Delayed Serotonin Syndrome in the Setting of Mixed Fluoxetine and Serotonin Antagonist Overdose. Am J Case Rep. 2018;19:604\u20137.","DOI":"10.12659\/AJCR.909063"},{"issue":"9","key":"10.1016\/j.ncl.2021.01.005_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ncl.2020.07.006","article-title":"Toxin-Induced Subacute Encephalopathy","volume":"38","author":"Lerner","year":"2020","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2021.01.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045125318818814","article-title":"Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques","volume":"9","author":"Ott","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.ncl.2021.01.005_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s13181-011-0167-1","article-title":"Cariotoxicity and serotonin syndrome complicating a milnacipran overdose","volume":"7","author":"Levine","year":"2011","journal-title":"J\u00a0Med Toxicol"},{"issue":"12","key":"10.1016\/j.ncl.2021.01.005_bib39","doi-asserted-by":"crossref","first-page":"A348","DOI":"10.1097\/01.ccm.0000440576.51720.18","article-title":"The clinical roller coaster severe serotonin syndrome","volume":"41","author":"Moseson","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ncl.2021.01.005_bib40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jclinane.2013.06.005","article-title":"Pharmacogenetic workup of perioperative serotonin syndrome","volume":"25","author":"Beatty","year":"2013","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.ncl.2021.01.005_bib41","first-page":"343","article-title":"Serotoninergic syndrome after the administration of clomipramine tablet in a critical patient","volume":"31","author":"Villar","year":"2007","journal-title":"Med Intesniva"},{"key":"10.1016\/j.ncl.2021.01.005_bib42","first-page":"233","article-title":"Serotonin syndrome in a postoperative patient","volume":"27","author":"Choudhury","year":"2011","journal-title":"J\u00a0Anesthesiol Ciln Pharmacol"},{"key":"10.1016\/j.ncl.2021.01.005_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"1","author":"38Velamoor","year":"1998","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.005_bib44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ncl.2021.01.005_bib46","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib47","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/JCP.0b013e31817ea9c1","article-title":"Neuroleptic malignant syndrome and the acute phase response","volume":"28","author":"Rosebush","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ncl.2021.01.005_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hup.483","article-title":"Olanzapine induced neuroleptic malignant syndrome-a care review","volume":"18","author":"Kogoj","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.ncl.2021.01.005_bib50","first-page":"208","article-title":"Neuroleptic malignant syndrome: long-term follow-up of 20 cases","volume":"52","author":"Pope","year":"1991","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.005_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-014-3807-8","article-title":"Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma","volume":"232","author":"Lang","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.10m06791","article-title":"Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database","volume":"73","author":"Nakamura","year":"2012","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib53","first-page":"477","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia","volume":"21","author":"Caroff","year":"1993","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ncl.2021.01.005_bib54","unstructured":"Denysenko L, Freudenreich O, Philbrick K, et\u00a0al. \u201cCatatonia in Medically Ill Patients An Evidence-Based Medicine ( EBM ) Monograph for Psychosomatic Medicine Practice.\u201d (2015). Available at: https:\/\/www.eapm.eu.com\/wp-content\/uploads\/2018\/06\/Catatonia_APM-EAPM_2015-04-17.pdf."},{"issue":"2","key":"10.1016\/j.ncl.2021.01.005_bib55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.005_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ncl.2021.01.005_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1573400511309020005","article-title":"Catatonia, malignant cataonia and neuroleptic malignant syndrome","volume":"9","author":"Mann","year":"2013","journal-title":"Curr Psychiatry Rev"},{"key":"10.1016\/j.ncl.2021.01.005_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.6.1.1","article-title":"Malignant Catatonia","volume":"6","author":"Philbrick","year":"1994","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2021.01.005_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3223(95)00552-8","article-title":"Neuroleptic malignant syndrome and catatonia: one entity or two?","volume":"39","author":"Fink","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ncl.2021.01.005_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0305-4179(90)90173-T","article-title":"Catatonia and burns","volume":"16","author":"Zarr","year":"1990","journal-title":"Burns"},{"key":"10.1016\/j.ncl.2021.01.005_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2190\/GTPP-MHH3-HKCP-R2NH","article-title":"Catatonia on the consultation-liaison service: a replication study","volume":"24","author":"Carroll","year":"1994","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.ncl.2021.01.005_bib62","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.pnpbp.2007.04.006","article-title":"Catatonia and consultaiton-liasion psychiatry study of 12 cases","volume":"31","author":"Cottencin","year":"2007","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ncl.2021.01.005_bib63","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.genhosppsych.2013.04.009","article-title":"Prevelance and clinical correlations of catatonia in older adults referred to a liaison psychiatry service in a general hospital","volume":"35","author":"Jaimes-Albornoz","year":"2013","journal-title":"Ger Hosp Psychiatry"},{"key":"10.1016\/j.ncl.2021.01.005_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rassmussen","year":"2016","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.ncl.2021.01.005_bib65","first-page":"302","article-title":"Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam","volume":"15","author":"Jacob","year":"2006","journal-title":"Neuropsychiatry Dis Treat"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:22:04Z","timestamp":1760005324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0733861921000050"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.01.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement Disorder Emergencies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}